UnknownNot Applicable

Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients

Italy200 participantsStarted 2020-12-20

Plain-language summary

Define the actual incidence of tracheal stenosis in patients who underwent either prolonged intubation or tracheostomy and to compare incidence, clinical course and outcome between COVID-19 and non-COVID-19 patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * prolonged intubation, defined as the permanence of naso or oro- tracheal tube for more than 7 days * tracheostomy, whether surgical or percutaneous * minimum of 2 months follow-up from hospital discharge * Positivity to SARS-CoV-2 infection confirmed using PCR on either nasal swab or bronchoalveolar lavage will be not an inclusion criterion; patients tested negative will be used as a control group Exclusion Criteria: * Pediatric patients (\< 18 years of age) * Patients without a minimum of 2 months follow-up from hospital discharge

What they're measuring

Incidence of tracheal stenosis following either prolonged intubation or tracheostomy in COVID-19 patients

Timeframe: 8 months

Clinical presentation of tracheal stenosis

Timeframe: 8 months

Clinical course of tracheal stenosis

Timeframe: 8 months

Outcome of tracheal stenosis

Timeframe: 8 months

Trial details

NCT IDNCT04686721

SponsorIstituto Clinico Humanitas

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-09

Contact for this trial

Umberto Cariboni, MD

+393385700988 umberto.cariboni@humanitas.it

View on ClinicalTrials.gov More Tracheal Stenosis trials